110 related articles for article (PubMed ID: 26300018)
1. Risk Factors for Hyperglycemia During Chemotherapy for Acute Lymphoblastic Leukemia Among Taiwanese Children.
Tsai MC; Huang HH; Chou YY; Cheng CN; Chen JS; Lin SJ
Pediatr Neonatol; 2015 Oct; 56(5):339-45. PubMed ID: 26300018
[TBL] [Abstract][Full Text] [Related]
2. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy.
Meenan CK; Kelly JA; Wang L; Ritchey AK; Maurer SH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27515. PubMed ID: 30362242
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.
Pollock NI; Flamand Y; Zhu J; Millington K; Stevenson K; Silverman LB; Vrooman LM; Cohen LE
Pediatr Blood Cancer; 2022 Jul; 69(7):e29505. PubMed ID: 34931744
[TBL] [Abstract][Full Text] [Related]
4. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Mullins J; Ferry RJ; DeAngulo G; Thomas PJ; Estrada J; Pitney A; Pollock BH
Pediatr Blood Cancer; 2005 Dec; 45(7):960-3. PubMed ID: 15700246
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
Lowas SR; Marks D; Malempati S
Pediatr Blood Cancer; 2009 Jul; 52(7):814-8. PubMed ID: 19260096
[TBL] [Abstract][Full Text] [Related]
6. Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.
Yoshida H; Imamura T; Saito AM; Takahashi Y; Suenobu S; Hasegawa D; Deguchi T; Hashii Y; Kawasaki H; Endo M; Hori H; Suzuki N; Kosaka Y; Kato K; Yumura-Yagi K; Hara J; Oda M; Sato A; Horibe K;
PLoS One; 2015; 10(8):e0136428. PubMed ID: 26317422
[TBL] [Abstract][Full Text] [Related]
7. The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL).
Dare JM; Moppett JP; Shield JP; Hunt LP; Stevens MC
Pediatr Blood Cancer; 2013 Dec; 60(12):E157-9. PubMed ID: 23868820
[TBL] [Abstract][Full Text] [Related]
8. Transient hyperglycemia during childhood acute lymphocytic leukemia chemotherapy: an old event revisited.
Spinola-Castro AM; Siviero-Miachon AA; Andreoni S; Tosta-Hernandez PD; Macedo CR; Lee ML
Clin Adv Hematol Oncol; 2009 Jul; 7(7):465-72. PubMed ID: 19701154
[TBL] [Abstract][Full Text] [Related]
9. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience.
Li MJ; Chang HH; Yang YL; Lu MY; Shao PL; Fu CM; Chou AK; Liu YL; Lin KH; Huang LM; Lin DT; Jou ST
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371256
[TBL] [Abstract][Full Text] [Related]
10. Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children With Acute Lymphoblastic Leukemia.
Gatzioura I; Papakonstantinou E; Dimitriadou M; Kourti M; Sidi V; Triantafyllou P; Koliouskas D; Christoforidis A
Pediatr Blood Cancer; 2016 Jul; 63(7):1181-4. PubMed ID: 27062362
[TBL] [Abstract][Full Text] [Related]
11. L-asparaginase-induced abnormality in plasma glucose level in patients of acute lymphoblastic leukemia admitted to a tertiary care hospital of Odisha.
Panigrahi M; Swain TR; Jena RK; Panigrahi A
Indian J Pharmacol; 2016; 48(5):595-598. PubMed ID: 27721550
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
J Pediatr; 2009 Jul; 155(1):73-8. PubMed ID: 19394046
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia.
Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
Pediatr Blood Cancer; 2008 Sep; 51(3):387-92. PubMed ID: 18523991
[TBL] [Abstract][Full Text] [Related]
14. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma.
Demedis J; Scarbro S; Suresh K; Maloney K; Forlenza GP
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e154-e160. PubMed ID: 36715999
[TBL] [Abstract][Full Text] [Related]
16. Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics.
Koltin D; Sung L; Naqvi A; Urbach SL
Support Care Cancer; 2012 Sep; 20(9):2009-15. PubMed ID: 22065148
[TBL] [Abstract][Full Text] [Related]
17. Body mass index predicts insulin resistance in survivors of pediatric acute lymphoblastic leukemia.
Lowas S; Malempati S; Marks D
Pediatr Blood Cancer; 2009 Jul; 53(1):58-63. PubMed ID: 19340854
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Hyperglycemia during Induction of Remission Phase of Pediatric Acute Lymphoblastic Leukemia.
Laila R; Islam A; Bhuiyan MM
Mymensingh Med J; 2016 Oct; 25(4):730-735. PubMed ID: 27941739
[TBL] [Abstract][Full Text] [Related]
19. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
[TBL] [Abstract][Full Text] [Related]
20. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia.
Roberson JR; Raju S; Shelso J; Pui CH; Howard SC
Pediatr Blood Cancer; 2008 Jun; 50(6):1207-12. PubMed ID: 18266226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
